CROI 2024 Program Guide

Interactive Symposia

Target Audience: This session is directed to trainee and senior scientists, clinicians, and others with a general interest in virology Level of Knowledge: It is assumed that the participants are familiar with the basics of the HIV-1 replication cycle and cell tropism

Conveners Owen Pornillos , University of Utah, Salt Lake City, UT, USA Melissa Kane , University of Pittsburgh, Pittsburgh, PA, USA

29 | 4:00 PM | HIV-1 Genome Packaging During Virion Assembly: Selecting the Right RNA Wei-Shau Hu , National Cancer Institute, Frederick, MD, USA

30 | 4:20 PM | Virion Maturation: Folding Into the Right Shape Mamuka Kvaratskhelia , University of Colorado, Aurora, CO, USA

31 | 4:40 PM | Virion Disassembly: Keeping it Together Until the Right Moment Gregory Towers , University College London, London, UK

5:00 PM | Audience Questions and Answers

Interactive Symposium-05 | New Frontiers in Hepatitis B 4:00 PM - 6:00 PM • Mile High Ballroom 4 CME Objectives: At the completion of the session, participants will be able to: • Describe the treatment, prophylaxis, and public health impact of hepatitis B in sub-Saharan Africa • Summarize the current understanding of novel hepatitis B biomarkers and their use in disease staging and therapeutic management • Identify host mechanisms responsible for control of hepatitis B and treatment modalities that seek to enhance these mechanisms to facilitate viral suppression • Describe the international management of hepatitis B Target Audience: This session is directed to epidemiologists, clinicians, immunologists, virologists, and public health officials who are interested in hepatitis B and similar infectious diseases Level of Knowledge: It is assumed that the participants are familiar with fundamental principles of epidemiology, microbiology, immunology, and clinical medicine as related to viral hepatitis Conveners Gilles Wandeler , University of Bern, Bern, Switzerland Gail Matthews , Kirby Institute, Sydney, Australia

Tuesday

CROI 2024 49

New Investigator Scholarship

LB

NIS

Late-Breaking